Parkinson disease gene therapy moves toward the clinic

被引：0

作者：

Anders Björklund

Olle Lindvall

机构：

[1] Wallenberg Neuroscience Center,

[2] Lund University,undefined

来源：

Nature Medicine | 2000年 / 6卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

Current therapies for Parkinson disease focus mainly on symptomatic relief, but gene therapy approaches may offer the prospect of halting or reversing the progress of the disease process itself. A recent study provides evidence that sustained delivery of glial cell line-derived neurotrophic factor to the nigrostriatal system provides neuroprotection and functional recovery in a primate model of Parkinson disease.

引用

页码：1207 / 1208

页数：1

共 27 条

[1]

Lin L-FH(1993)GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons Science 260 1130-1132

[2]

Doherty DH(1997)Studies on neuroprotective and regenerative effects of GDNF in a partial lesion model of Parkinson's disease Neurobiol. Dis. 4 186-200

[3]

Lile JD(1998)Neuroprotective and neurorestorative properties of GDNF Ann. Neurol. 44 S121-S125

[4]

Bektesh S(1999)Clinicopathological findings following intraventricular glial-derived neurotrophic factor treatment in a patient with Parkinson's disease Ann. Neurol. 46 419-424

[5]

Collins F(1997)Dopaminergic neurons protected from degeneration by GDNF gene therapy Science 275 838-841

[6]

Björklund A(2000)Long-term rAAV-mediated gene transfer of GDNF in the rat Parkinson's model: intrastriatal but not intranigral transduction promotes functional regeneration in the lesioned nigrostriatal system J. Neurosci. 20 4686-4700

[7]

Rosenblad C(2000)Self-inactivating lentiviral vectors with enhanced transgene expression as potential gene transfer system in Parkinson's disease Hum. Gene Ther. 11 179-190

[8]

Winkler C(2000) protection of nigral dopamine neurons by lentiviral gene transfer of the novel GDNF-family member Neublastin/Artemin Mol. Cell Neurosci. 15 199-214

[9]

Kirik D(1997)Highly efficient and sustained gene transfer in adult neurons with a lentivirus vector J. Virol. 71 6641-6649

[10]

Gash DM(2000)Lentiviral vectors: turning a deadly foe into a therapeutic agent Gene Ther. 7 20-23

← 1 2 3 →